Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 4.065
-0.035 (-0.85%)
Nov 3, 2025, 2:42 PM CET
Synthaverse Revenue
In the year 2024, Synthaverse had annual revenue of 71.76M PLN with 22.44% growth. Synthaverse had revenue of 6.28M in the quarter ending June 30, 2025, a decrease of -58.65%.
Revenue
71.76M
Revenue Growth
+22.44%
P/S Ratio
3.99
Revenue / Employee
300.23K
Employees
239
Market Cap
286.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 71.76M | 13.15M | 22.44% |
| Dec 31, 2023 | 58.61M | 8.22M | 16.32% |
| Dec 31, 2022 | 50.38M | 9.23M | 22.43% |
| Dec 31, 2021 | 41.15M | 995.00K | 2.48% |
| Dec 31, 2020 | 40.16M | 1.05M | 2.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| Celon Pharma | 206.22M |